Michael Ceulemans, Lynn Bruyninckx, Evelyne Van den Broucke, Karel Allegaert, Kristel Van Calsteren, Isabel Spriet, Charlotte Quintens
{"title":"Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?","authors":"Michael Ceulemans, Lynn Bruyninckx, Evelyne Van den Broucke, Karel Allegaert, Kristel Van Calsteren, Isabel Spriet, Charlotte Quintens","doi":"10.1093/ijpp/riag101","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study assessed the frequency and type of potentially teratogenic medications administered to hospitalized pregnant women.</p><p><strong>Methods: </strong>A retrospective study was conducted among pregnant women hospitalized between 2021 and 2023.</p><p><strong>Key findings: </strong>Among 155 individuals, 1058 medications were administered (mean: 6.8 per patient), including 77 potentially teratogenic medications (7.3%), corresponding to 27.1% of the cohort. Indomethacin (18.7%), tramadol (18.1%), and sufentanil (7.7%) were most common. Such medications were used nearly twice as often during non-pregnancy versus pregnancy-related admissions (12.7% vs. 6.8%).</p><p><strong>Conclusions: </strong>The findings support the potential value of pregnancy-related monitoring, however, improving pregnancy documentation, especially in non-obstetric wards, remains essential.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmacy Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ijpp/riag101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study assessed the frequency and type of potentially teratogenic medications administered to hospitalized pregnant women.
Methods: A retrospective study was conducted among pregnant women hospitalized between 2021 and 2023.
Key findings: Among 155 individuals, 1058 medications were administered (mean: 6.8 per patient), including 77 potentially teratogenic medications (7.3%), corresponding to 27.1% of the cohort. Indomethacin (18.7%), tramadol (18.1%), and sufentanil (7.7%) were most common. Such medications were used nearly twice as often during non-pregnancy versus pregnancy-related admissions (12.7% vs. 6.8%).
Conclusions: The findings support the potential value of pregnancy-related monitoring, however, improving pregnancy documentation, especially in non-obstetric wards, remains essential.
期刊介绍:
The International Journal of Pharmacy Practice (IJPP) is a Medline-indexed, peer reviewed, international journal. It is one of the leading journals publishing health services research in the context of pharmacy, pharmaceutical care, medicines and medicines management. Regular sections in the journal include, editorials, literature reviews, original research, personal opinion and short communications. Topics covered include: medicines utilisation, medicine management, medicines distribution, supply and administration, pharmaceutical services, professional and patient/lay perspectives, public health (including, e.g. health promotion, needs assessment, health protection) evidence based practice, pharmacy education. Methods include both evaluative and exploratory work including, randomised controlled trials, surveys, epidemiological approaches, case studies, observational studies, and qualitative methods such as interviews and focus groups. Application of methods drawn from other disciplines e.g. psychology, health economics, morbidity are especially welcome as are developments of new methodologies.